Evaluation safety and efficiency of early administration of Tranexamic acid in trauma patient

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220507054758N1

Enrollment

Registered

2022-05-24

Start date

2022-06-05

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trauma.

Interventions

Intervention 1: Intervention group: Patients who receive 1 gram Tranexamic Acid during 10 minutes intravenous infusion. Intervention 2: Control group: Patients who receive intravenous infusion of Norm

Eligibility

Sex/Gender

All

Age

15 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients admitted with multiple trauma over than 15 years old with ABC trauma score more than 2 scores patient satisfaction to study

Exclusion criteria

Exclusion criteria: pregnancy brain injuries coaglopathy renal failure using anticoaglants

Design outcomes

Primary

Measure	Time frame
Mortality. Timepoint: All days of hospital admission. Method of measurement: Discharge or death of patient.;Hemoglobin decrease. Timepoint: All days of hospital admission. Method of measurement: Hemoglobin in laboratory data.;Blood transfusion. Timepoint: All days of hospital admission. Method of measurement: Evaluate patient records.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmin Esfandyari

Zanjan University of Medical Sciences

Aminesf1369@gmail.com+98 41 3443 2869

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026